<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2020-02-26" modified="2021-04-07" version="8">
<accession>A0A2U8U2L5</accession>
<name>ASR6_SARSH</name>
<protein>
<recommendedName>
<fullName evidence="5">Alpha-humulene synthase asR6</fullName>
<ecNumber evidence="3">4.2.3.104</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="5">Xenovulene A biosynthesis cluster protein R6</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="5">asR6</name>
</gene>
<organism>
<name type="scientific">Sarocladium schorii</name>
<name type="synonym">Acremonium strictum (strain IMI 501407)</name>
<dbReference type="NCBI Taxonomy" id="2203296"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Fungi</taxon>
<taxon>Dikarya</taxon>
<taxon>Ascomycota</taxon>
<taxon>Pezizomycotina</taxon>
<taxon>Sordariomycetes</taxon>
<taxon>Hypocreomycetidae</taxon>
<taxon>Hypocreales</taxon>
<taxon>Sarocladiaceae</taxon>
<taxon>Sarocladium</taxon>
<taxon>unclassified Sarocladium</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="1963" last="1963">
<title>Three previously unrecognised classes of biosynthetic enzymes revealed during the production of xenovulene A.</title>
<authorList>
<person name="Schor R."/>
<person name="Schotte C."/>
<person name="Wibberg D."/>
<person name="Kalinowski J."/>
<person name="Cox R.J."/>
</authorList>
<dbReference type="PubMed" id="29773797"/>
<dbReference type="DOI" id="10.1038/s41467-018-04364-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="J. Pharmacol. Exp. Ther." volume="282" first="513" last="520">
<title>Regulation of neuronal and recombinant GABA(A) receptor ion channels by xenovulene A, a natural product isolated from Acremonium strictum.</title>
<authorList>
<person name="Thomas P."/>
<person name="Sundaram H."/>
<person name="Krishek B.J."/>
<person name="Chazot P."/>
<person name="Xie X."/>
<person name="Bevan P."/>
<person name="Brocchini S.J."/>
<person name="Latham C.J."/>
<person name="Charlton P."/>
<person name="Moore M."/>
<person name="Lewis S.J."/>
<person name="Thornton D.M."/>
<person name="Stephenson F.A."/>
<person name="Smart T.G."/>
</authorList>
<dbReference type="PubMed" id="9262310"/>
</citation>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2007" name="Chem. Commun. (Camb.)" volume="39" first="4053" last="4055">
<title>Characterisation of 3-methylorcinaldehyde synthase (MOS) in Acremonium strictum: first observation of a reductive release mechanism during polyketide biosynthesis.</title>
<authorList>
<person name="Bailey A.M."/>
<person name="Cox R.J."/>
<person name="Harley K."/>
<person name="Lazarus C.M."/>
<person name="Simpson T.J."/>
<person name="Skellam E."/>
</authorList>
<dbReference type="PubMed" id="17912413"/>
<dbReference type="DOI" id="10.1039/b708614h"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2010" name="Chem. Commun. (Camb.)" volume="46" first="5331" last="5333">
<title>Catalytic role of the C-terminal domains of a fungal non-reducing polyketide synthase.</title>
<authorList>
<person name="Fisch K.M."/>
<person name="Skellam E."/>
<person name="Ivison D."/>
<person name="Cox R.J."/>
<person name="Bailey A.M."/>
<person name="Lazarus C.M."/>
<person name="Simpson T.J."/>
</authorList>
<dbReference type="PubMed" id="20552126"/>
<dbReference type="DOI" id="10.1039/c0cc01162b"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="1 2 3">Alpha-humulene synthase; part of the gene cluster that mediates the biosynthesis of xenovulene A, an unusual meroterpenoid that has potent inhibitory effects on the human gamma-aminobutyrate A (GABAA) benzodiazepine receptor (PubMed:29773797). The first step of xenovulene A biosynthesis is the biosynthesis of 3-methylorcinaldehyde performed by the non-reducing polyketide synthase aspks1 (PubMed:17912413, PubMed:29773797, PubMed:20552126). The salicylate hydroxylase asL1 then catalyzes the oxidative dearomatization of 3-methylorcinaldehyde to yield a dearomatized hydroxycyclohexadione (PubMed:29773797). The 2-oxoglutarate-dependent dioxygenase asL3 further catalyzes the oxidative ring expansion to provide the first tropolone metabolite (PubMed:29773797). The cytochrome P450 monooxygenase asR2 allows the synthesis of tropolone hemiacetal (PubMed:29773797). In parallel, a previously unrecognised class of terpene cyclase, asR6, produces alpha-humulene from farnesylpyrophosphate (FPP) (PubMed:29773797). The putative Diels-Alderase asR5 probably catalyzes the formation of the tropolone-humulene skeleton by linking humulene and the polyketide moiety (PubMed:29773797). Oxidative-ring contractions catalyzed by asL4 and asL6 then processively remove carbon atoms from the polyketide to yield xenovulene A (PubMed:29773797).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="3">
<text>(2E,6E)-farnesyl diphosphate = (1E,4E,8E)-alpha-humulene + diphosphate</text>
<dbReference type="Rhea" id="RHEA:31895"/>
<dbReference type="ChEBI" id="CHEBI:5768"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:175763"/>
<dbReference type="EC" id="4.2.3.104"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="3">
<dbReference type="Rhea" id="RHEA:31896"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="3">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="pathway" evidence="3">
<text>Secondary metabolite biosynthesis; terpenoid biosynthesis.</text>
</comment>
<comment type="induction">
<text evidence="3">Expression is significantly up-regulated under xenovulene A producing condition.</text>
</comment>
<comment type="biotechnology">
<text evidence="4">Xenovulene A is a natural product exhibiting little structural resemblance with classical benzodiazepines yet is able to displace high-affinity ligand binding to the benzodiazepine site of the gamma-aminobutyrate A (GABAA) receptor and could be potentially used as an anti-depressant with reduced addictive properties.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the terpene synthase family. Alpha-humulene synthase eupE subfamily.</text>
</comment>
<dbReference type="EC" id="4.2.3.104" evidence="3"/>
<dbReference type="EMBL" id="MG736817">
<property type="protein sequence ID" value="AWM95795.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="SMR" id="A0A2U8U2L5"/>
<dbReference type="UniPathway" id="UPA00213"/>
<dbReference type="GO" id="GO:0080017">
<property type="term" value="F:alpha-humulene synthase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="RHEA"/>
</dbReference>
<dbReference type="GO" id="GO:0016114">
<property type="term" value="P:terpenoid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<feature type="chain" description="Alpha-humulene synthase asR6" id="PRO_0000449161">
<location>
<begin position="1"/>
<end position="430"/>
</location>
</feature>
<evidence key="1" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17912413"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20552126"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29773797"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9262310"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="29773797"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="430" mass="48387" checksum="C1B95D04415D078B" modified="2018-09-12" version="1">MPVTTPTKMATLTTKQMWQTIKDYFGDGFVTGSAPISYNVHTCDMQLQPDSGIHAASDGIHYGVQISEDSMPLFSIMGDTAAPPCTCHRVDEIVKHIDEFLERAPEALPDDGAITSGKPCDTNPDQVSLYAMRDSLSWWVHWGGNLRPEHYWKQIYIGFAAIPDDVQISPREFLDGTYRYLGHTWDDCLSGLEEEGVSPDEIEFANMCMWRQMLTQWLEKADPELLPLLKGKISLMLQYRVLTANTLGCLALFMNATADPKDGPIHYADSSYEMEIASVAQCVTLDMAKEAMGILQGERTEVVAGDRAQRKRELRWIYVRCMQILESQPHAHMLRRYGSAGLHYVPMMDRYLERVSGHTRFPIRDGAARILERFINRAELPKESEDINPNGRSLKVSAKMNGNGQLHHEVNGNAKLHLEAERPDVTTAVG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>